CD274 and neoplasm: Tumor tissue-derived biomarkers such as programmed death-ligand 1 (PD-L1) expression, interferon-γ signature, CD8 T-cell infiltration, and tumor mutational burden are potential sources for the identification of candidate biomarkers.